Article metrics

Original article
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

 

Online download statistics by month:

Online download statistics by month: May 2015 to December 2021

AbstractFullPdf
May 2015745273376
Jun 2015698410346
Jul 20151438396442
Aug 20151109224263
Sep 2015624173213
Oct 2015343132155
Nov 2015429191152
Dec 2015344196135
Jan 2016365166182
Feb 2016404219177
Mar 2016221156137
Apr 201619110695
May 201616811788
Jun 20161899883
Jul 20161309892
Aug 20161158780
Sep 20161089463
Oct 20161019763
Nov 20161218884
Dec 20166711153
Jan 2017936743
Feb 2017375691
Mar 2017296342
Apr 20172016953
May 20172012338
Jun 20175413580
Jul 20171068634
Aug 201712211044
Sep 20171148333
Oct 20171128025
Nov 20171208833
Dec 201717811028
Jan 201828923558
Feb 201819311344
Mar 201825116743
Apr 201827511640
May 201828918935
Jun 201813910128
Jul 201817617830
Aug 20189116727
Sep 20188615225
Oct 201815817632
Nov 201815920837
Dec 201811217433
Jan 201913016836
Feb 20198615229
Mar 20198716041
Apr 20197614538
May 2019814733
Jun 2019664648
Jul 2019633830
Aug 2019654726
Sep 2019593726
Oct 2019684130
Nov 2019483221
Dec 2019442619
Jan 20201096829
Feb 2020665018
Mar 2020604232
Apr 2020533215
May 2020584024
Jun 2020614520
Jul 2020583825
Aug 2020582818
Sep 2020593632
Oct 2020714133
Nov 2020503127
Dec 2020412525
Jan 2021704330
Feb 2021483429
Mar 2021483222
Apr 2021483831
May 2021393522
Jun 2021262719
Jul 2021353521
Aug 202138377
Sep 2021656523
Oct 2021826459
Nov 2021815923
Dec 20211168722
Total1344685495238